Stock RYTM RHYTHM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Rhythm Pharmaceuticals, Inc.

Equities

RYTM

US76243J1051

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
40.38 USD +0.45% Intraday chart for Rhythm Pharmaceuticals, Inc. +2.62% -12.16%
05-08 BofA Downgrades Rhythm Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $42 From $49 MT
05-07 Rhythm Pharmaceuticals' Q1 Net Loss Widens as Revenue Increases; Shares Fall Pre-Bell MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Rhythm Pharmaceuticals Insider Sold Shares Worth $735,600, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $707,005, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $627,520, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $647,114, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $1,046,360, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $384,336, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $364,573, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $437,819, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $894,329, According to a Recent SEC Filing
MT
Rhythm Pharmaceuticals Insider Sold Shares Worth $260,287, According to a Recent SEC Filing
MT
Verve Therapeutics Appoints Frederick Fiedorek as Chief Medical Officer
MT
Insider Sell: Rhythm Pharmaceuticals
MT
Insider Sell: Rhythm Pharmaceuticals
MT
Rhythm Pharmaceuticals, Inc. Announces Executive Changes, Effective on August 11, 2023
CI
Rhythm Pharmaceuticals, Inc. Announces Continuing Directors Not Standing for Re-Election as Directors
CI
Rhythm Pharmaceuticals Appoints Dana Washburn, M.D., as Senior Vice President of Clinical Development
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RYTM Stock
  4. News Rhythm Pharmaceuticals, Inc.
  5. Insiders